Overview

Pharmacological and Behavioral Treatment After Bariatric Surgery

Status:
Recruiting
Trial end date:
2028-11-17
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness of behavioral and pharmacologic treatment, alone and combined, for improvements in weight loss, cardiovascular risk factors, and psychosocial functioning following metabolic and bariatric surgery.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Treatments:
Bupropion
Naltrexone